» Articles » PMID: 37954388

Expression Patterns of Claudins in Cancer

Overview
Journal Heliyon
Specialty Social Sciences
Date 2023 Nov 13
PMID 37954388
Authors
Affiliations
Soon will be listed here.
Abstract

Claudins are four-transmembrane proteins, which were found in tight junctions. They maintain cell barriers and regulate cell differentiation and proliferation. They are involved in maintaining cellular polarity and normal functions. Different claudins show different expression patterns. The expression level and localization of claudins are altered in various cancers. They promote or inhibit proliferation, invasion, and migration of cancer cells through multiple signaling pathways. Therefore, claudins may serve as diagnostic markers, novel therapeutic targets, and prognostic risk factors. The important roles of claudins in cancer aroused our great interest. In the present review, we provide a summary of insights into expression patterns of claudins in cancer, which is more comprehensive and provides new ideas for further research.

Citing Articles

Extrajunctional CLDN10 cooperates with LAT1 and accelerates clear cell renal cell carcinoma progression.

Onagi A, Sugimoto K, Kobayashi M, Sato Y, Kobayashi Y, Yaginuma K Cell Commun Signal. 2024; 22(1):588.

PMID: 39639312 PMC: 11619122. DOI: 10.1186/s12964-024-01964-5.


Tight Junctions and Cancer: Targeting Claudin-1 and Claudin-4 in Thyroid Pathologies.

Borowczak J, Laszczych D, Olejnik K, Michalski J, Gutowska A, Kula M Pharmaceuticals (Basel). 2024; 17(10).

PMID: 39458944 PMC: 11509894. DOI: 10.3390/ph17101304.


S-acylation of Ca transport proteins in cancer.

Kouba S, Demaurex N Chronic Dis Transl Med. 2024; 10(4):263-280.

PMID: 39429488 PMC: 11483607. DOI: 10.1002/cdt3.146.


Claudins in Cancer: A Current and Future Therapeutic Target.

Hana C, Thaw Dar N, Galo Venegas M, Vulfovich M Int J Mol Sci. 2024; 25(9).

PMID: 38731853 PMC: 11083183. DOI: 10.3390/ijms25094634.


Computational Models of Claudin Assembly in Tight Junctions and Strand Properties.

McGuinness S, Sajjadi S, Weber C, Khalili-Araghi F Int J Mol Sci. 2024; 25(6).

PMID: 38542338 PMC: 10970134. DOI: 10.3390/ijms25063364.

References
1.
Karanjawala Z, Illei P, Ashfaq R, Infante J, Murphy K, Pandey A . New markers of pancreatic cancer identified through differential gene expression analyses: claudin 18 and annexin A8. Am J Surg Pathol. 2008; 32(2):188-96. PMC: 2678811. DOI: 10.1097/PAS.0b013e31815701f3. View

2.
Ashikari D, Takayama K, Obinata D, Takahashi S, Inoue S . CLDN8, an androgen-regulated gene, promotes prostate cancer cell proliferation and migration. Cancer Sci. 2017; 108(7):1386-1393. PMC: 5497721. DOI: 10.1111/cas.13269. View

3.
Li Z, Xuan W, Huang L, Chen N, Hou Z, Lu B . Claudin 10 acts as a novel biomarker for the prognosis of patients with ovarian cancer. Oncol Lett. 2020; 20(1):373-381. PMC: 7285858. DOI: 10.3892/ol.2020.11557. View

4.
Zhou S, Piao X, Wang C, Wang R, Song Z . Identification of claudin‑1, ‑3, ‑7 and ‑8 as prognostic markers in human laryngeal carcinoma. Mol Med Rep. 2019; 20(1):393-400. PMC: 6580001. DOI: 10.3892/mmr.2019.10265. View

5.
Leotlela P, Wade M, Duray P, Rhode M, Brown H, Rosenthal D . Claudin-1 overexpression in melanoma is regulated by PKC and contributes to melanoma cell motility. Oncogene. 2006; 26(26):3846-56. DOI: 10.1038/sj.onc.1210155. View